ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,405,049 | +142583.2% | 645,020 | 0.0% | 0.02% | +43.8% |
| Q4 2022 | $4,489 | -99.9% | 645,020 | -0.1% | 0.02% | +23.1% |
| Q3 2022 | $3,447,000 | +33.6% | 645,470 | -0.2% | 0.01% | +30.0% |
| Q2 2022 | $2,581,000 | -40.4% | 646,817 | -33.7% | 0.01% | -16.7% |
| Q1 2022 | $4,334,000 | +3988.7% | 975,139 | +3594.8% | 0.01% | – |
| Q4 2021 | $106,000 | -82.6% | 26,392 | -61.9% | 0.00% | -100.0% |
| Q3 2021 | $608,000 | -91.6% | 69,219 | -89.2% | 0.00% | -92.0% |
| Q2 2021 | $7,232,000 | +1031.8% | 638,313 | +1087.0% | 0.02% | +733.3% |
| Q1 2021 | $639,000 | -65.4% | 53,774 | -80.0% | 0.00% | -62.5% |
| Q4 2020 | $1,847,000 | -47.4% | 269,183 | -43.2% | 0.01% | -60.0% |
| Q3 2020 | $3,514,000 | – | 474,276 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |